𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Correlation of serum anti-DNA topoisomerase I antibody levels with disease severity and activity in systemic sclerosis

✍ Scribed by Paul Q. Hu; Noreen Fertig; Thomas A. Medsger Jr.; Timothy M. Wright

Publisher
John Wiley and Sons
Year
2003
Tongue
English
Weight
147 KB
Volume
48
Category
Article
ISSN
0004-3591

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Clinical subsets, skin thickness progres
Clinical subsets, skin thickness progression rate, and serum antibody levels in systemic sclerosis patients with anti–topoisomerase I antibody
✍ Achini Perera; Noreen Fertig; Mary Lucas; Tatiana S. Rodriguez-Reyna; Paul Hu; V 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 129 KB 👁 1 views

## Abstract ## Objective To describe the clinical and laboratory features and natural history of the disease in systemic sclerosis (SSc; scleroderma) patients with anti–topoisomerase I (anti–topo I) antibody who have different skin thickness progression rates (STPRs). ## Methods SSc patients (n

Direct binding of anti–DNA topoisomerase
Direct binding of anti–DNA topoisomerase I autoantibodies to the cell surface of fibroblasts in patients with systemic sclerosis
✍ Jill Hénault; Mélanie Tremblay; Isabelle Clément; Yves Raymond; Jean-Luc Senécal 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 265 KB 👁 1 views

## Abstract ## Objective Fibroblasts play a crucial role in the development of systemic sclerosis (SSc), and antifibroblast antibodies (AFAs) capable of inducing a proinflammatory phenotype in fibroblasts have been detected in the sera of SSc patients. This study examined the prevalence of AFAs in

Enhancement of anti-DNA topoisomerase I
Enhancement of anti-DNA topoisomerase I autoantibody response after lung cancer in patients with systemic sclerosis: A report of two cases
✍ Masataka Kuwana; Takao Fujii; Tsuneyo Mimori; Junichi Kaburaki 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 496 KB 👁 1 views

A Report of Two Cases MASATAKA KUWANA, TAKA0 FUJII, TSUNEYO MIMORI, and JUNICHI KABURAKI Anti-DNA topoisomerase I (anti-topo I) antibody profiles were compared before and after lung cancer in 2 patients with systemic sclerosis (SSc). Both patients developed adenocarcinoma of the lung late in the cou